Fernando Docobo-Perez
Fernando Docobo-Perez
Departamento de Microbiología. Universidad Sevilla.
Verified email at - Homepage
Cited by
Cited by
Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii
MJ McConnell, J Domínguez-Herrera, Y Smani, R López-Rojas, ...
Infection and immunity 79 (1), 518-526, 2011
Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii
R López-Rojas, J Domínguez-Herrera, MJ McConnell, F Docobo-Peréz, ...
Journal of Infectious Diseases 203 (4), 545-548, 2011
Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii
ME Pachón-Ibánez, F Docobo-Pérez, R López-Rojas, ...
Antimicrobial agents and chemotherapy 54 (3), 1165-1172, 2010
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance
F Docobo-Pérez, GL Drusano, A Johnson, J Goodwin, S Whalley, ...
Antimicrobial Agents and Chemotherapy 59 (9), 5602-5610, 2015
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and …
L López-Cerero, E Picón, C Morillo, JR Hernández, F Docobo, J Pachón, ...
Clinical microbiology and infection 16 (2), 132-136, 2010
Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli
J Machuca, A Briales, G Labrador, P Díaz-de-Alba, R López-Rojas, ...
Journal of Antimicrobial Chemotherapy 69 (12), 3203-3215, 2014
Studies on the antimicrobial activity of cecropin A–melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii
MJ Rodríguez-Hernández, J Saugar, F Docobo-Pérez, BG de la Torre, ...
Journal of Antimicrobial Chemotherapy 58 (1), 95-100, 2006
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam
ME Pachón-Ibáñez, F Fernandez-Cuenca, F Docobo-Pérez, J Pachon, ...
Journal of Antimicrobial Chemotherapy 58 (3), 689-692, 2006
Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli
F Docobo-Pérez, P Nordmann, J Domínguez-Herrera, R López-Rojas, ...
International journal of antimicrobial agents 39 (3), 251-254, 2012
Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells
Y Smani, F Docobo-Pérez, R López-Rojas, J Domínguez-Herrera, ...
Journal of Biological Chemistry 287 (32), 26901-26910, 2012
Quinolone resistance reversion by targeting the SOS response
E Recacha, J Machuca, P Díaz de Alba, M Ramos-Güelfo, ...
MBio 8 (5), 10.1128/mbio. 00971-17, 2017
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL …
F Docobo-Pérez, L López-Cerero, R López-Rojas, P Egea, ...
Antimicrobial agents and chemotherapy 57 (5), 2109-2113, 2013
Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like
F Fernández-Cuenca, Y Smani, MC Gómez-Sánchez, F Docobo-Pérez, ...
International journal of antimicrobial agents 38 (6), 548-549, 2011
Population pharmacokinetics of teicoplanin in children
V Ramos-Martín, S Paulus, S Siner, E Scott, K Padmore, P Newland, ...
Antimicrobial agents and chemotherapy 58 (11), 6920-6927, 2014
Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1
JM Rodriguez-Martinez, C Pichardo, I García, ME Pachón-Ibañez, ...
Clinical microbiology and infection 14 (7), 691-697, 2008
Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus …
J Domínguez-Herrera, F Docobo-Pérez, R López-Rojas, C Pichardo, ...
Antimicrobial agents and chemotherapy 56 (2), 613-617, 2012
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates
V Ramos-Martín, A Johnson, J Livermore, L McEntee, J Goodwin, ...
Journal of Antimicrobial Chemotherapy 71 (4), 992-1002, 2016
Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae
M Ballestero-Téllez, F Docobo-Pérez, JM Rodríguez-Martínez, ...
Clinical Microbiology and Infection 23 (5), 325-331, 2017
Impact of AAC(6′)-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli
J Machuca, M Ortiz, E Recacha, P Díaz-De-Alba, F Docobo-Perez, ...
Journal of Antimicrobial Chemotherapy 71 (11), 3066-3071, 2016
Pharmacodynamics of voriconazole in children: further steps along the path to true individualized therapy
LJ Huurneman, M Neely, A Veringa, F Docobo Pérez, V Ramos-Martin, ...
Antimicrobial agents and chemotherapy 60 (4), 2336-2342, 2016
The system can't perform the operation now. Try again later.
Articles 1–20